AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
AN UPDATE ON DRUG-INTERACTIONS WITH ZIDOVUDINE
Authors: PISCITELLI SC POLIS MA
Citation: Sc. Piscitelli et Ma. Polis, AN UPDATE ON DRUG-INTERACTIONS WITH ZIDOVUDINE, AIDS patient care and STDs, 12(9), 1998, pp. 687-690
PERIPHERAL EXPANSION OF PREEXISTING MATURE T-CELLS IS AN IMPORTANT MEANS OF CD4(-CELL REGENERATION HIV-INFECTED ADULTS() T)
Authors: WALKER RE CARTER CS MUUL L NATARAJAN V HERPIN BR LEITMAN SF KLEIN HG MULLEN CA METCALF JA BASELER M FALLOON J DAVEY RT KOVACS JA POLIS MA MASUR H BLAESE RM LANE HC
Citation: Re. Walker et al., PERIPHERAL EXPANSION OF PREEXISTING MATURE T-CELLS IS AN IMPORTANT MEANS OF CD4(-CELL REGENERATION HIV-INFECTED ADULTS() T), Nature medicine, 4(7), 1998, pp. 852-856
SPONTANEOUS AND SUSTAINED RESOLUTION OF CMV RETINITIS IN PATIENTS RECEIVING HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY
Authors: WHITCUP SM CUNNINGHAM ET POLIS MA FORTIN E
Citation: Sm. Whitcup et al., SPONTANEOUS AND SUSTAINED RESOLUTION OF CMV RETINITIS IN PATIENTS RECEIVING HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY, British journal of ophthalmology, 82(7), 1998, pp. 845-846
GUIDELINES FOR THE TREATMENT OF CYTOMEGALOVIRUS DISEASES IN PATIENTS WITH AIDS IN THE ERA OF POTENT ANTIRETROVIRAL THERAPY - RECOMMENDATIONS OF AN INTERNATIONAL PANEL
Authors: WHITLEY RJ JACOBSON MA FRIEDBERG DN HOLLAND GN JABS DA DIETERICH DT HARDY WD POLIS MA DEUTSCH TA FEINBERG J SPECTOR SA WALMSLEY S DREW WL POWDERLY WG GRIFFITHS PD BENSON CA KESSLER HA
Citation: Rj. Whitley et al., GUIDELINES FOR THE TREATMENT OF CYTOMEGALOVIRUS DISEASES IN PATIENTS WITH AIDS IN THE ERA OF POTENT ANTIRETROVIRAL THERAPY - RECOMMENDATIONS OF AN INTERNATIONAL PANEL, Archives of internal medicine, 158(9), 1998, pp. 957-969
SENSITIVITY OF CD4+ CELL COUNTS AND OCULAR SYMPTOMS IN SCREENING FOR CYTOMEGALOVIRUS RETINITIS
Authors: LERTSUMITKUL S POLIS MA WHITCUP SM
Citation: S. Lertsumitkul et al., SENSITIVITY OF CD4+ CELL COUNTS AND OCULAR SYMPTOMS IN SCREENING FOR CYTOMEGALOVIRUS RETINITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 3401-3401
THERAPEUTIC EFFECT OF COMBINATION ANTIRETROVIRAL THERAPY ON CYTOMEGALOVIRUS RETINITIS
Authors: WHITCUP SM FORTIN E NUSSENBLATT RB POLIS MA MUCCIOLI C BELFORT R
Citation: Sm. Whitcup et al., THERAPEUTIC EFFECT OF COMBINATION ANTIRETROVIRAL THERAPY ON CYTOMEGALOVIRUS RETINITIS, JAMA, the journal of the American Medical Association, 277(19), 1997, pp. 1519-1520
CLARITHROMYCIN LOWERS PLASMA ZIDOVUDINE LEVELS IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: POLIS MA PISCITELLI SC VOGEL S WITEBSKY FG CONVILLE PS PETTY B KOVACS JA DAVEY RT WALKER RE FALLOON J METCALF JA CRAFT C LANE HC MASUR H
Citation: Ma. Polis et al., CLARITHROMYCIN LOWERS PLASMA ZIDOVUDINE LEVELS IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1709-1714
SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS
Authors: DAVEY RT CHAITT DG PISCITELLI SC WELLS M KOVACS JA WALKER RE FALLOON J POLIS MA METCALF JA MASUR H FYFE G LANE HC
Citation: Rt. Davey et al., SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS, The Journal of infectious diseases, 175(4), 1997, pp. 781-789
DRUG-INTERACTIONS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: PISCITELLI SC FLEXNER C MINOR JR POLIS MA MASUR H
Citation: Sc. Piscitelli et al., DRUG-INTERACTIONS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 23(4), 1996, pp. 685-693
A PHASE-I II PILOT-STUDY OF THE SAFETY OF THE ADOPTIVE TRANSFER OF SYNGENEIC GENE-MODIFIED CYTOTOXIC T-LYMPHOCYTES IN HIV-INFECTED IDENTICAL-TWINS - CELL-GENESYS-INC PROTOCOL T-9401-BB-IND-5610/
Authors: WALKER RE BLAESE RM DAVEY RT FALLOON J MULLEN C POLIS MA FINER M MCGUIRE B ROBERTS M ZSEBO K HAVRILLA N
Citation: Re. Walker et al., A PHASE-I II PILOT-STUDY OF THE SAFETY OF THE ADOPTIVE TRANSFER OF SYNGENEIC GENE-MODIFIED CYTOTOXIC T-LYMPHOCYTES IN HIV-INFECTED IDENTICAL-TWINS - CELL-GENESYS-INC PROTOCOL T-9401-BB-IND-5610/, Human gene therapy, 7(3), 1996, pp. 367-400
GENE-THERAPY FOR AIDS USING RETROVIRAL-MEDIATED GENE-TRANSFER TO DELIVER HIV-1 ANTISENSE TAR AND TRANSDOMINANT REV PROTEIN GENES TO SYNGENEIC LYMPHOCYTES IN HIV-1-INFECTED IDENTICAL-TWINS
Authors: MORGAN RA WALKER R BLAESE RM CARTER CS DAVEY RT FALLOON J KLEIN H LANE HC LEITMAN SF POLIS MA
Citation: Ra. Morgan et al., GENE-THERAPY FOR AIDS USING RETROVIRAL-MEDIATED GENE-TRANSFER TO DELIVER HIV-1 ANTISENSE TAR AND TRANSDOMINANT REV PROTEIN GENES TO SYNGENEIC LYMPHOCYTES IN HIV-1-INFECTED IDENTICAL-TWINS, Human gene therapy, 7(10), 1996, pp. 1281-1306
RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/
Authors: DAVEY RT CHAITT DG REED GF FREIMUTH WW HERPIN BR METCALF JA EASTMAN PS FALLOON J KOVACS JA POLIS MA WALKER RE MASUR H BOYLE J COLEMAN S COX SR WATHEN L DAENZER CL LANE HC
Citation: Rt. Davey et al., RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1657-1664
CONTROLLED TRIAL OF INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITHTHE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: KOVACS JA VOGEL S ALBERT JM FALLOON J DAVEY RT WALKER RE POLIS MA SPOONER K METCALF JA BASELER M FYFE G LANE HC
Citation: Ja. Kovacs et al., CONTROLLED TRIAL OF INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITHTHE HUMAN-IMMUNODEFICIENCY-VIRUS, The New England journal of medicine, 335(18), 1996, pp. 1350-1356
INHIBITION OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA BY A CHIMERIC ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: WALKER RE SPOONER KM KELLY G MCCLOSKEY V WOODY JN FALLOON J BASELER M PISCITELLI SC DAVEY RT POLIS MA KOVACS JA MASUR H LANE HC
Citation: Re. Walker et al., INHIBITION OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA BY A CHIMERIC ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 174(1), 1996, pp. 63-68
COMBINATION THERAPY WITH DIDANOSINE AND INTERFERON-ALPHA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS OF A PHASE I II TRIAL/
Authors: KOVACS JA BECHTEL C DAVEY RT FALLOON J POLIS MA WALKER RE METCALF JA DAVEY V PISCITELLI SC BASELER M DEWAR R SALZMAN NP MASUR H LANE HC
Citation: Ja. Kovacs et al., COMBINATION THERAPY WITH DIDANOSINE AND INTERFERON-ALPHA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS OF A PHASE I II TRIAL/, The Journal of infectious diseases, 173(4), 1996, pp. 840-848
CIDOFOVIR - A VIEWPOINT
Authors: POLIS MA
Citation: Ma. Polis, CIDOFOVIR - A VIEWPOINT, Drugs, 52(2), 1996, pp. 231-231
EFFECT OF SPLENECTOMY ON T-LYMPHOCYTE SUBSETS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: ZURLO JJ WOOD L GAGLIONE MM POLIS MA
Citation: Jj. Zurlo et al., EFFECT OF SPLENECTOMY ON T-LYMPHOCYTE SUBSETS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 20(4), 1995, pp. 768-771
SURVIVAL AND DISTRIBUTION OF GENETICALLY-MODIFIED CELLS IN IDENTICAL-TWINS DISCORDANT FOR HIV-1 INFECTION
Authors: WALKER RE CARTER CS MUUL L NATARAJAN V HERPIN BR LEITMAN SF KLEIN HG FALLOON J DAVEY RT KOVACS JA POLIS MA MASUR H BLAESE RM LANE HC
Citation: Re. Walker et al., SURVIVAL AND DISTRIBUTION OF GENETICALLY-MODIFIED CELLS IN IDENTICAL-TWINS DISCORDANT FOR HIV-1 INFECTION, AIDS research and human retroviruses, 11, 1995, pp. 166-166
PROMISING NEW TREATMENTS FOR CYTOMEGALOVIRUS RETINITIS
Authors: POLIS MA MASUR H
Citation: Ma. Polis et H. Masur, PROMISING NEW TREATMENTS FOR CYTOMEGALOVIRUS RETINITIS, JAMA, the journal of the American Medical Association, 273(18), 1995, pp. 1457-1459
CLINICAL PHARMACOKINETICS OF CIDOFOVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
Authors: CUNDY KC PETTY BG FLAHERTY J FISHER PE POLIS MA WACHSMAN M LIETMAN PS LALEZARI JP HITCHCOCK MJM JAFFE HS
Citation: Kc. Cundy et al., CLINICAL PHARMACOKINETICS OF CIDOFOVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(6), 1995, pp. 1247-1252
ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITHHUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA
Authors: POLIS MA SPOONER KM BAIRD BF MANISCHEWITZ JF JAFFE HS FISHER PE FALLOON J DAVEY RT KOVACS JA WALKER RE WHITCUP SM NUSSENBLATT RB LANE HC MASUR H
Citation: Ma. Polis et al., ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITHHUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA, Antimicrobial agents and chemotherapy, 39(4), 1995, pp. 882-886
INCREASES IN CD4 T-LYMPHOCYTES WITH INTERMITTENT COURSES OF INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PRELIMINARY-STUDY
Authors: KOVACS JA BASELER M DEWAR RJ VOGEL S DAVEY RT FALLOON J POLIS MA WALKER RE STEVENS R SALZMAN NP METCALF JA MASUR H LANE HC
Citation: Ja. Kovacs et al., INCREASES IN CD4 T-LYMPHOCYTES WITH INTERMITTENT COURSES OF INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PRELIMINARY-STUDY, The New England journal of medicine, 332(9), 1995, pp. 567-575
VIRUS-SPECIFIC ANTIBODY-RESPONSES TO HUMAN CYTOMEGALOVIRUS (HCMV) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS WITH HCMV RETINITIS
Authors: BOPPANA SB POLIS MA KRAMER AA BRITT WJ KOENIG S
Citation: Sb. Boppana et al., VIRUS-SPECIFIC ANTIBODY-RESPONSES TO HUMAN CYTOMEGALOVIRUS (HCMV) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS WITH HCMV RETINITIS, The Journal of infectious diseases, 171(1), 1995, pp. 182-185
DIAGNOSING CYTOMEGALOVIRUS PNEUMONIA - COMMENT ON THE CONCISE COMMUNICATION BY AGLAS ET-AL
Authors: SNELLER MC POLIS MA
Citation: Mc. Sneller et Ma. Polis, DIAGNOSING CYTOMEGALOVIRUS PNEUMONIA - COMMENT ON THE CONCISE COMMUNICATION BY AGLAS ET-AL, Arthritis and rheumatism, 38(10), 1995, pp. 1528-1528
PHOSPHONOFORMATE FOR CMV RETINITIS IN AIDS - REPLY
Authors: LANE HC POLIS MA MURPHY R NUSSENBLATT AB MASUR H
Citation: Hc. Lane et al., PHOSPHONOFORMATE FOR CMV RETINITIS IN AIDS - REPLY, The American journal of medicine, 98(3), 1995, pp. 317-318
Risultati: 1-25 | 26-34